Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-23-125486

Chief Financial Officer acquired 42,554 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kolean Chad J Chief Financial Officer 2023-12-08 Grant or award +42,554 42,578 D
Derivatives
Kolean Chad J Chief Financial Officer 2023-06-23 Grant or award · Stock option (right to buy) +104,000 104,000 D
Loading xslF345X05/tm2332764-2_4seq1.xml…